Skip to content
Subscriber Only

Trump-Backed Virus Drug May Be Taken by 15,000 Mumbai Residents

  • Quarantined, high risk cases to be given anti-malarial drug
  • Drug is unproven in its ability to ward off novel coronavirus
People stand in line to get tested for the the coronavirus inside Dharavi, in Mumbai on April 16.

People stand in line to get tested for the the coronavirus inside Dharavi, in Mumbai on April 16.

Photographer: Indranil Mukherjee/AFP via Getty Images

Updated on

As many as 15,000 people in Mumbai, including many in Dharavi, Asia’s most crowded slum, will be given an anti-malarial drug as a preventive therapy to ward off the deadly coronavirus.

The first-of-its-kind mass experiment of using hydroxychloroquine as a prophylaxis is being undertaken in the state of Maharashtra - home to India’s financial center that’s racing to curb the pathogen. Mumbai has emerged as the nation’s biggest virus hotspot, reporting the maximum number of infected cases and deaths.